• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2 型特发性黄斑毛细血管扩张症。

Type 2 idiopathic macular telangiectasia.

机构信息

Retina-Vitreous Service, Aravind Eye Hospital & Postgraduate Institute of Ophthalmology, Madurai, Tamil Nadu, India.

出版信息

Retina. 2012 Feb;32(2):265-74. doi: 10.1097/IAE.0b013e31822091b0.

DOI:10.1097/IAE.0b013e31822091b0
PMID:21968508
Abstract

PURPOSE

To describe the natural course of Type 2 idiopathic macular telangiectasia in terms of visual outcomes, causes of visual loss, and incidence of subretinal neovascular membranes (SRNV).

METHODS

This retrospective observational case series consisted of chart review of 104 outpatients (203 eyes; 66 women, 38 men) who were diagnosed to have Type 2 idiopathic macular telangiectasia by clinical examination and fluorescein angiography between January 2000 and December 2008. Visual and anatomic outcomes were analyzed during a minimum follow-up of 1 year.

RESULTS

The mean age of the patients was 57 years (range, 40-74 years). Nineteen eyes (18 patients) presented with SRNV; the number increased to 29 eyes (14%; 23 patients) by the final visit (mean follow-up, 31 months). Diabetes was common (59%) though retinopathy was initially absent or mild to moderate in 99% patients. Mean logarithm of the minimum angle of resolution best-corrected visual acuity declined from 0.35 to 0.43 by the last visit (P < 0.0001) overall; final mean logarithm of the minimum angle of resolution best-corrected visual acuity was 0.61 (20/80) in the eyes with SRNV and 0.40 (20/50) in eyes without SRNV. The latter group started with better best-corrected visual acuity than SRNV group and remained better at 1-year, 2-year, and final follow-ups (P ≤ 0.0002). Overall, 30 eyes (15%; 24 patients) lost ≥ 2 Snellen lines, the main causes being SRNV and intraretinal pigment migration. Of 128 eyes (including SRNV) with best-corrected visual acuity ≥ 20/40 at baseline, 98 (77%) retained stable visual status; 74 (71%) patients retained best-corrected visual acuity of 20/40 or better at least in 1 eye.

CONCLUSION

Over a follow-up of approximately 3 years, most eyes with Type 2 idiopathic macular telangiectasia starting with good vision were found to retain status quo; sight-threatening complications developed in a minority of eyes; most patients retained good vision at least in 1 eye.

摘要

目的

描述 2 型特发性黄斑毛细血管扩张症在视力结果、视力丧失原因和视网膜下新生血管膜(SRNV)发生率方面的自然病程。

方法

本回顾性观察性病例系列研究纳入了 2000 年 1 月至 2008 年 12 月期间通过临床检查和荧光素血管造影诊断为 2 型特发性黄斑毛细血管扩张症的 104 名门诊患者(203 只眼;66 名女性,38 名男性)的图表回顾。在至少 1 年的随访期间分析了视力和解剖学结果。

结果

患者的平均年龄为 57 岁(范围,40-74 岁)。19 只眼(18 名患者)出现 SRNV;在最后一次就诊时,这一数字增加到 29 只眼(14%;23 名患者)(平均随访 31 个月)。尽管 99%的患者最初没有或仅有轻度至中度视网膜病变,但糖尿病很常见(59%)。总的来说,最佳矫正视力的最小角度分辨率对数从最后一次就诊时的 0.35 下降到 0.43(P < 0.0001);在有 SRNV 的眼中,最终的平均最小角度分辨率对数最佳矫正视力为 0.61(20/80),在没有 SRNV 的眼中为 0.40(20/50)。后一组在最佳矫正视力方面开始优于 SRNV 组,并在 1 年、2 年和最后随访时保持更好(P ≤ 0.0002)。总的来说,30 只眼(15%;24 名患者)视力丧失≥2 行,主要原因是 SRNV 和视网膜内色素迁移。在基线时最佳矫正视力≥20/40 的 128 只眼中(包括 SRNV),98 只(77%)保持稳定的视力状态;74 只(71%)患者至少在 1 只眼中保持 20/40 或更好的最佳矫正视力。

结论

在大约 3 年的随访中,大多数开始视力良好的 2 型特发性黄斑毛细血管扩张症患者被发现保持现状;少数患者出现威胁视力的并发症;大多数患者至少在 1 只眼中保持良好的视力。

相似文献

1
Type 2 idiopathic macular telangiectasia.2 型特发性黄斑毛细血管扩张症。
Retina. 2012 Feb;32(2):265-74. doi: 10.1097/IAE.0b013e31822091b0.
2
Intravitreal bevacizumab for treatment of proliferative and nonproliferative type 2 idiopathic macular telangiectasia.玻璃体内注射贝伐单抗治疗增生型和非增生型 2 型特发性黄斑毛细血管扩张症。
Retina. 2011 Oct;31(9):1848-55. doi: 10.1097/IAE.0b013e31820d3feb.
3
Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.玻璃体内雷珠单抗治疗炎症性脉络膜新生血管。
Retina. 2011 May;31(5):871-9. doi: 10.1097/IAE.0b013e3182003ca8.
4
Retinal angiomatous proliferation: natural history and progression of visual loss.视网膜血管瘤样增生:自然病程及视力丧失的进展
Retina. 2009 Jun;29(6):732-9. doi: 10.1097/IAE.0b013e3181a395cb.
5
Change in visual function after macular translocation with 360 degrees retinectomy for neovascular age-related macular degeneration.360度视网膜切除术黄斑转位治疗新生血管性年龄相关性黄斑变性后的视觉功能变化
Ophthalmology. 2004 Sep;111(9):1715-24. doi: 10.1016/j.ophtha.2004.03.022.
6
Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.玻璃体内雷珠单抗(Lucentis)治疗分支静脉阻塞相关性黄斑水肿:一项前瞻性研究的九个月结果。
Retina. 2010 Jun;30(6):893-902. doi: 10.1097/IAE.0b013e3181cd4894.
7
Open globe injuries with positive intraocular cultures: factors influencing final visual acuity outcomes.眼内培养阳性的开放性眼球损伤:影响最终视力结果的因素
Ophthalmology. 2003 Aug;110(8):1560-6. doi: 10.1016/S0161-6420(03)00497-4.
8
LONG-TERM OUTCOMES OF INTRAVITREAL BEVACIZUMAB THERAPY FOR SUBRETINAL NEOVASCULARIZATION SECONDARY TO IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2.玻璃体内注射贝伐单抗治疗继发于2型特发性黄斑毛细血管扩张症的视网膜下新生血管的长期预后
Retina. 2016 Nov;36(11):2150-2157. doi: 10.1097/IAE.0000000000001035.
9
Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration.雷珠单抗单药治疗渗出性年龄相关性黄斑变性的注射频率和视力结果评估。
Ophthalmology. 2009 Sep;116(9):1740-7. doi: 10.1016/j.ophtha.2009.05.033. Epub 2009 Jul 29.
10
Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.微视野计和眼底自发荧光在糖尿病性黄斑水肿中的应用:阈下微脉冲二极管激光与改良早期治疗糖尿病性视网膜病变研究激光光凝比较。
Retina. 2010 Jun;30(6):908-16. doi: 10.1097/IAE.0b013e3181c96986.

引用本文的文献

1
Progressive inner retinal neurodegeneration in non-proliferative macular telangiectasia type 2.2型非增殖性黄斑毛细血管扩张症中的进行性视网膜内层神经变性。
Br J Ophthalmol. 2025 Feb 24;109(3):401-407. doi: 10.1136/bjo-2023-325115.
2
Long-Term Outcomes in Macular Telangiectasia Type 2 With Subretinal Neovascularization.2型黄斑毛细血管扩张症合并视网膜下新生血管的长期预后
J Vitreoretin Dis. 2020 Jun 17;4(5):386-392. doi: 10.1177/2474126420927149. eCollection 2020 Sep-Oct.
3
Co-existing retinal pathologies: Diagnostic challenges in diabetic retinopathy.
并存的视网膜病变:糖尿病视网膜病变的诊断挑战
Indian J Ophthalmol. 2021 Nov;69(11):2931. doi: 10.4103/ijo.IJO_2504_21.
4
Long term follow-up of visual acuity and incidence of subretinal neovascularization in Mactel Type 2 in 82 Eyes.82 只眼的 Mactel 型 2 中视力和脉络膜新生血管发生率的长期随访。
Semin Ophthalmol. 2022 Feb 17;37(2):136-141. doi: 10.1080/08820538.2021.1929347. Epub 2021 May 23.
5
Idiopathic macular telangiectasis type 2 and co-existent diabetic retinopathy.2型特发性黄斑毛细血管扩张症与并存的糖尿病视网膜病变
Int J Retina Vitreous. 2017 Dec 25;3:50. doi: 10.1186/s40942-017-0103-x. eCollection 2017.
6
Retinal energy demands control vascular supply of the retina in development and disease: The role of neuronal lipid and glucose metabolism.视网膜能量需求在发育和疾病中控制视网膜的血管供应:神经元脂质和葡萄糖代谢的作用。
Prog Retin Eye Res. 2018 May;64:131-156. doi: 10.1016/j.preteyeres.2017.11.002. Epub 2017 Nov 22.
7
Risk factors in patients with macular telangiectasia 2A in an Asian population: A case-control study.亚洲人群中黄斑毛细血管扩张2A型患者的危险因素:一项病例对照研究。
Indian J Ophthalmol. 2017 Sep;65(9):830-834. doi: 10.4103/ijo.IJO_85_17.
8
Clinical applications of optical coherence tomography in the posterior pole: the 2011 José Manuel Espino Lecture - Part II.光学相干断层扫描在后极部的临床应用:2011年何塞·曼努埃尔·埃斯皮诺讲座 - 第二部分
Clin Ophthalmol. 2013;7:2181-206. doi: 10.2147/OPTH.S51158. Epub 2013 Nov 8.
9
Diagnosis of subretinal neovascularization associated with idiopathic juxtafoveal retinal telangiectasia - fluorescein angiography versus spectral-domain optical coherence tomography.与特发性黄斑旁视网膜毛细血管扩张相关的视网膜下新生血管的诊断——荧光素血管造影与频域光学相干断层扫描对比
Graefes Arch Clin Exp Ophthalmol. 2014 Apr;252(4):549-53. doi: 10.1007/s00417-013-2491-4. Epub 2013 Oct 23.
10
Long-term course in type 2 idiopathic macular telangiectasia.2 型特发性黄斑毛细血管扩张症的长期病程。
Graefes Arch Clin Exp Ophthalmol. 2013 Nov;251(11):2513-20. doi: 10.1007/s00417-013-2346-z. Epub 2013 Apr 25.